2 companies list nepafenac as a human prescription drug in the openFDA NDC Directory, led by Harrow Eye, LLC, Novartis Pharmaceuticals Corporation. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.

Who supplies nepafenac active ingredient?

5 companies list nepafenac as a bulk ingredient, including CARBOGEN AMCIS AG, FDC Limited, Medichem SA, Micro Labs Limited.

Drug

Who makes nepafenac?

2 companies list nepafenac as a human prescription drug, including under the names ILEVRO, NEVANAC. Forms: suspension/ drops. Routes: ophthalmic.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing nepafenac

Company	Forms	Application	NDCs	Registered sites
Harrow Eye, LLC	suspension/ drops	NDANDA021862, NDA203491	2	0
Novartis Pharmaceuticals CorporationSwitzerland	suspension/ drops	NDANDA203491	1	20

Bulk ingredient listings

CARBOGEN AMCIS AGSwitzerland · 1 NDC
FDC LimitedIndia · 1 NDC
Medichem SASpain · 1 NDC
Micro Labs LimitedIndia · 1 NDC
Siegfried Grafton, Inc. · 1 NDC

Orange Book patents

3 unexpired patents list nepafenac as the active ingredient, expiring between Jan 2027 and Mar 2032. Application holder: HARROW EYE LLC.

Enquiry

Common questions

Who makes nepafenac?: 2 companies list nepafenac as a human prescription drug in the openFDA NDC Directory, led by Harrow Eye, LLC, Novartis Pharmaceuticals Corporation. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Who supplies nepafenac active ingredient?: 5 companies list nepafenac as a bulk ingredient, including CARBOGEN AMCIS AG, FDC Limited, Medichem SA, Micro Labs Limited.